Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN||1821288 / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Asthenia, Influenza like illness, Injection site pain, Muscular weakness, Vision blurred, Emotional distress, Muscle fatigue, Head titubation
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Current Illness: Abstains from alcohol; Fibromyalgia; Marijuana use (a joint per day for pain)
Preexisting Conditions: Comments: The patient had no known allergies. The patient did not have any drug abuse/illicit drug use.
Diagnostic Lab Data:
CDC 'Split Type': USJNJFOC20210733688
Write-up: HEAD TREMORS; BLURRED VISION; CONSTANT MUSCLE FAILURE; FLU-LIKE SYMPTOMS; SEVERE MUSCLE WEAKNESS; INJECTION SITE SORENESS; WEAKNESS, NO ENERGY, NO STRENGTH; EMOTIONALLY DEGRADING; This spontaneous report received from a patient concerned a 51 year old female. The patient''s height, and weight were not reported. The patient''s concurrent conditions included fibromyalgia, 1 pack per day medical marijuana a joint per day for pain, and non alcohol user, and other pre-existing medical conditions included the patient had no known allergies. the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821288, and expiry: 15-SEP-2021) dose was not reported, administered on 03-JUL-2021 11:00:00 for prophylactic vaccination. No concomitant medications were reported. On JUL-2021, the subject experienced emotionally degrading. On 04-JUL-2021, the subject experienced head tremors. On 04-JUL-2021, the subject experienced blurred vision. On 04-JUL-2021, the subject experienced constant muscle failure. On 04-JUL-2021, the subject experienced flu-like symptoms. On 04-JUL-2021, the subject experienced severe muscle weakness. On 04-JUL-2021, the subject experienced injection site soreness. On 04-JUL-2021, the subject experienced weakness, no energy, no strength. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms, and weakness, no energy, no strength on 06-JUL-2021, had not recovered from injection site soreness, severe muscle weakness, head tremors, blurred vision, and constant muscle failure, and the outcome of emotionally degrading was not reported. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166